Acute tacrolimus toxicity due to concomitant use of ritonavir (with nirmatrelvir as Paxlovid)

被引：0
|
作者：
Browne, Evan [1 ,4 ]
White, Cameron [2 ]
Darley, David [3 ]
Murnion, Bridin [4 ]
机构：
[1] St Vincents Hosp, Clin Pharmacol & Toxicol Adv Trainee, Sydney, Australia
[2] St Vincents Hosp, Resp Med Adv Trainee, Sydney, Australia
[3] St Vincents Hosp, Sydney, Australia
[4] UNSW Sydney, Fac Med & Hlth, Sch Clin Med, St Vincents Healthcare Clin Campus,Clin Pharmacol, Sydney, Australia
来源：
AUSTRALIAN PRESCRIBER | 2024年 / 47卷 / 06期
关键词：
COVID-19; drug interactions; nirmatrelvir; Paxlovid; ritonavir; tacrolimus;
D O I：
10.18773/austprescr.2024.052
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：192 / 193
页数：2
相关论文
共 50 条
  • [41] Nirmatrelvir/ritonavir Use With Tacrolimus in Lung Transplant Recipients: A Single-center Case Series
    Dewey, Katherine W. W.
    Yen, Bo
    Lazo, Jose
    Seijo, Leslie
    Jariwala, Ripal
    Shah, Rupal J. J.
    Quan, David
    Carpenter, Bethanne
    Singer, Jonathan Paul
    Breen, Karen
    Hays, Steven
    Florez, Rebecca
    TRANSPLANTATION, 2023, 107 (05) : 1200 - 1205
  • [42] Nirmatrelvir+ritonavir/tacrolimus interactionVarious toxicities following drug interaction, drug toxicity and off-label use: case report
    Reactions Weekly, 2023, 1968 (1) : 241 - 241
  • [43] Abnormally Elevated Blood Tacrolimus Level Following the Concomitant Use of Nirmatrelvir/Ritonavir With Extended-Release Tacrolimus in a Post-lung Transplant Patient: A Case Report and a Literature Review
    Yoshida, Hikari
    Umemura, Takumi
    Ito, Soichiro
    Mizuno, Takahito
    Mutoh, Yoshikazu
    Yamada, Tetsuya
    Kimura, Tomoki
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [44] Efficacy of Nirmatrelvir/Ritonavir (Paxlovid) for COVID-19 in Vaccinated Patients With Inflammatory Bowel Disease
    Mikhail, Inas
    Desai, Aakash
    Crosby, Sheena
    Hashash, Jana G.
    Hayney, Mary
    Caldera, Freddy
    Kochhar, Gursimran
    Farraye, Francis A. A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (12S): : S15 - S15
  • [45] Nirmatrelvir/ritonavir - A New Culprit of Acute Pancreatitis
    Abi-Saleh, Simon P.
    Doumet, Amanda Abi
    Ayyagari, Radhika
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S1244 - S1245
  • [46] Nirmatrelvir+ritonavir/tacrolimusIncreased tacrolimus level following drug interction
    Reactions Weekly, 2024, 2002 (1) : 378 - 378
  • [47] Pancreatitis Secondary to Paxlovid-Induced Tacrolimus Toxicity
    Schwartz, Michael
    Gheysens, Katherine
    Francis, Pilin
    Dalal, Kunal K.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S1198 - S1199
  • [48] Nirmatrelvir and Ritonavir (Paxlovid) Prognostication: Unveiling Utilization Trends with Neural Network Time Series Forecasting
    Smith, Terry L.
    Shumunov, Ashir
    Martin, Jennifer L.
    Cunningham, Fran E.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 198 - 198
  • [49] Nirmatrelvir+ritonavir/tacrolimus/tozinameranIncrease tacrolimus drug level and vaccine failure: case report
    Reactions Weekly, 2022, 1918 (1) : 388 - 388
  • [50] FOSPHENYTOIN TO POTENTIALLY INDUCE CLEARANCE OF TACROLIMUS LEVEL SECONDARY TO NIRMATRELVIR/RITONAVIR
    Schwarz, Jacob
    Robinson, John
    Rusk, Ann
    Heilman, Raymond
    Cartin-Ceba, Rodrigo
    CRITICAL CARE MEDICINE, 2024, 52
12345